Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.

The firm reported positive results this week from a biomarker analysis in a Phase IIb trial of OST-HER2, which it will submit to regulators.

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to ...

After stomach cancer is diagnosed, a team of cancer specialists will work together with you to develop a personalized ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

Amid a year of cancer battles for him and his wife, 1973 Manogue graduate Tony Peroddy will be inducted into the school’s ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

Pancreatitis is excruciatingly painful, especially after eating. The pancreas is behind the lower part of the stomach, ...

Ever-smokers receiving immunotherapy for gastric and esophageal cancers showed better survival outcomes but higher relapse ...

For most people, heartburn is an occasional annoyance and source of temporary discomfort. But for some, chronic heartburn can lead to more dangerous conditions — potentially even pre-cancerous ones.